An array of cutting-edge
therapeutic products

Dynapar AQ is a novel Diclofenac injection manufactured by the Aquatech Process, which provides the full dose of 75 mg Diclofenac in just 1 ml.
The Aquatech process provides the optimal concentration of Diclofenac in an aqueous solvent system, thereby, providing the full therapeutic dose in a smaller volume.
The reduced volume of injection and the low viscosity of the solution in Dynapar AQ ensures that the injection is virtually painless.
The multiple advantages of Dynapar AQ have been demonstrated through a number of clinical trials. No wonder, Dynapar AQ has won several awards and accolades.

Phlebotroy QPS is used in prevention and treatment of thrombophlebitis.

Phlebotroy QPS is a new generation topical solution which ensures higher penetration of Heparin as compared to conventional ointment/gel. It is backed by multicentric clinical trials and is manufactured using the globally patented QPS technology. Each ml of Phlebotroy QPS contains 1000 IU/ml of Heparin Sodium.

Phlebotroy QPS offers significant reduction in the length of venous lesion, better improvement in grades of Phlebitis and complete resolution of Phlebitis in 90% of the patients as compared to heparin gel.  Prophylactic application of Phlebotroy QPS is effective in preventing development of superficial thrombophlebitis. Phlebotroy QPS maintains the patency of AV fistula in patients undergoing dialysis.

Zolswift-SL is the world’s first sublingual spray (3.85% w/v) to treat insomnia. Comparative clinical studies between Zolswift-SL Spray (3.85% w/v) and Zolpidem Tartrate tablets clearly established that Zolswift-SL Spray achieves faster therapeutic concentrations in blood compared to Zolpidem oral tablets. The pharmacodynamic assessment showed a quick onset of action with Zolswift-SL Sublingual Spray in comparison to oral Zolpidem tablets.

Designed for short-term insomnia treatment, Zolswift-SL sets a new benchmark in sleep therapy with its unique delivery mechanism and proven efficacy, offering a reliable solution for those seeking fast and effective relief from insomnia. It is protected by patents in India, the US, Europe, and over 100 other countries.

Troypofol is an emulsion injection of Propofol and is manufactured by Nanoemulsion Technology. It is manufactured in an ultramodern facility equipped with a high-speed homogenizer which ensures control on globule size of the emulsion. Troypofol Nanoemulsion Technology results in small, uniform and controlled globule size of Troypofol Nanoemulsion which provides better efficacy of Troypofol and less incidence of pain.

To provide therapeutically meaningful extended delivery of drugs, Troikaa has developed Duo Phase Technology. Through this technology, the drug dose is split judiciously into two components, where one part delivers the drug immediately and the other releases the drug in a sustained release pattern. Thus drug delivery is biphasic and ensures the requisite pharmacokinetic profile. Drugs developed using this technology are extended-release Paracetamol tablets of 650 mg and 1000 mg (Xykaa Extend). Products manufactured using Duo Phase Technology are presented in stylized tablets which graphically represent the biphasic drug delivery.

Myonit Insta is a fast acting Nitrate with the onset of action in 114 seconds it dissolves immediately when kept under tongue & provides immediate relief from anginal pain. Myonit Insta is packed in an amber glass bottle, ensuring undiminished potency throughout its shelf life. It is also available in an easy-to-carry patient-friendly pack.